Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations that the pharmacy benefit manager inflated drug prices, including for insulin, to boost ...

The Federal Trade Commission reached a landmark settlement with Express Scripts over allegations it inflated drug prices, particularly for insulin, to increase profits. The agreement bans practices ...

The most important issue the industry faces is healthcare and drug pricing. With 2026 being a key election year, regulators ...

The Maryland Supreme Court has vacated Baltimore’s $266 million opioid verdict and sent the case back to circuit court.

In a remarkable display of unity, independent candidate Apexa Soni secured a win in Godhra's communally sensitive Ward 7, a ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

Site-neutral payment has advanced from E&M to drug administration codes, but stakeholders warn rapid, simultaneous policy ...

A Maryland Supreme Court decision vacating a $152 million opioid verdict is not expected to change Baltimore’s immediate ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson Drugmakers including ...

FTC settlement frameworks for major PBMs mandate transparency to plan sponsors, fee-based remuneration, limits on spread ...